Artelo Biosciences, Inc. (ARTL)
NASDAQ: ARTL · Real-Time Price · USD
6.61
-0.43 (-6.11%)
At close: Apr 6, 2026, 4:00 PM EDT
6.50
-0.11 (-1.66%)
After-hours: Apr 6, 2026, 7:59 PM EDT

Artelo Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Nov '21
5711132580
Market Cap Growth
68.29%-31.77%-19.14%-45.90%-69.03%19.23%
Enterprise Value
5.297.438.562.977.2555.17
Last Close Price
6.613.6619.0825.2052.02170.10
PE Ratio
--0.10-0.35-0.45-0.81-
PB Ratio
--5.813.791.141.282.83
P/TBV Ratio
-2.52-0.991.200.350.422.83
P/FCF Ratio
--0.87-1.30-1.63-3.09-
P/OCF Ratio
--0.87-1.30-1.63-3.09-
EV/EBITDA Ratio
--0.65-0.85-0.30-0.70-
EV/EBIT Ratio
--0.65-0.85-0.30-0.70-
EV/FCF Ratio
--0.87-1.03-0.36-0.91-
Debt / Equity Ratio
-0.50-0.500.0200.000.00
Debt / EBITDA Ratio
-0.06-0.06-0.010.00-0.01-
Debt / FCF Ratio
-0.08-0.08-0.010.00-0.01-
Net Debt / Equity Ratio
-0.06-0.06-0.78-0.88-0.90-0.87
Net Debt / EBITDA Ratio
-0.01-0.010.221.051.70-
Net Debt / FCF Ratio
-0.01-0.010.271.272.18-
Quick Ratio
0.150.151.328.0817.5737.69
Current Ratio
0.170.171.448.5118.3638.47
Return on Equity (ROE)
-1625.11%-1625.11%-134.52%-59.63%-42.29%0.00%
Return on Assets (ROA)
-304.15%-304.15%-113.95%-59.34%-41.62%0.00%
Return on Invested Capital (ROIC)
13823.03%13823.03%-979.93%-590.19%-370.10%0.00%
Return on Capital Employed (ROCE)
-1355.20%-1355.20%-137.73%-63.70%-43.07%0.00%
Earnings Yield
-246.87%-1026.23%-287.74%-223.81%-123.18%0.00%
FCF Yield
-163.31%-115.31%-77.10%-61.28%-32.34%0.00%
Buyback Yield / Dilution
-91.62%-91.62%-8.70%-4.62%66.51%-579.53%
Total Shareholder Return
-91.62%-91.62%-8.70%-4.62%66.51%-579.53%
Updated Feb 24, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q